Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials
Clinical trial NCT03477175 · COMPLETED
Trial details
- NCT number
- NCT03477175
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2023-12-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.